TrialBritish journal of cancer2024

First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial.

Anne Hansen Ree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.